INSM

Insmed Incorporated (INSM)

Last Price$81.1(3.0%)
Market Cap$14.5B
LTM Diluted EPS
($5.6)
YoY Growth
+4.7%
3Y CAGR
+13.0%
5Y CAGR
+13.0%
Stock quality & Intrinsic value
6/10
51.1% overvalued

Insmed Incorporated Diluted EPS

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Diluted EPS
($7.0)
($8.4)
($5.9)
($1.7)
($1.3)
$9.3
($0.5)
($2.6)
($1.6)
($1.6)
($1.8)
($2.0)
($2.9)
($2.9)
($4.2)
($3.0)
($3.0)
($3.9)
($3.9)
($5.3)
INSM
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for INSM and see if it's the right time to invest.
Dive in

Insmed Incorporated (INSM) Diluted EPS comparison analysis

Crunching data... Almost there!

INSM key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Insmed Incorporated's Diluted EPS?

As of today, Insmed Incorporated's last 12-month Diluted EPS is ($5.6), based on the financial report for Dec 31, 2024 (Q4 2024).

2) What is Insmed Incorporated's Diluted EPS growth rate?

Over the last year, Insmed Incorporated's Diluted EPS growth was 4.7%. The average annual Diluted EPS growth rates for Insmed Incorporated have been 15.9% over the past three years, 13.0% over the past five years.

3) Is Insmed Incorporated's Diluted EPS growth rate Good?

Over the last year, Insmed Incorporated's Diluted EPS growth was 4.7%, which is higher than industry growth of (0.2%). It indicates that Insmed Incorporated's Diluted EPS growth is Good.